Moreover, SphK2 overexpression enhanced glioma cell epithelial-to-mesenchymal transition through the AKT/β-catenin pathway, a downstream target of S1P (Chen et al., 2019). The gene discussed is SPHK2; the disease is central nervous system cancer.